Single-use Bioprocessing Connectors Market (2026 - 2033)

Single-use Bioprocessing Connectors Market Summary

The global single-use bioprocessing connectors market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.9 billion in 2026 to USD 4.9 billion by 2033, at a CAGR of 14.2% from 2026 to 2033. The North America single-use bioprocessing connectors market held the largest share of 47.2% of the global market in 2025.This growth is driven by the increasing adoption of single-use bioprocessing systems, the rising production of biologics and biosimilars, and continuous advancements in connector design and functionality. Growing emphasis on reducing contamination risks and improving operational efficiency.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By product: Aseptic connectors segment led the global single-use bioprocessing connectors industry and accounted for a share of 47.0% in 2025.
• By application: Upstream bioprocessing segment led the market and accounted for a share of 43.0% in 2025.
• By end use: Biopharmaceutical & pharmaceutical companies segment led the market and accounted for a share of 43.7% in 2025.

Regional Highlights

• Largest regional market: North America (47.2% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The single-use bioprocessing connectors industry in the U.S. held the largest revenue share in 2025.

Market Size & Forecast

• Market size in 2025: USD 1.7 Billion
• Estimated market size in 2026: USD 1.9 Billion
• Projected market size by 2033: USD 4.9 Billion
• CAGR (2026-2033): 14.2%

To learn more about this report, Download Free Sample Report

Market Dynamics

Market Characteristics & Concentration

The single-use bioprocessing connectors industry has seen moderate to high levels of innovation, driven by the growing adoption of flexible biomanufacturing, sterility requirements, and advances in automation. Innovation is focused on enhancing aseptic processing, improving material compatibility, integrating smart technologies, and ensuring regulatory compliance. Key areas of innovation include genderless, self-sealing, automated sterile, and pre-sterilized, ready-to-use connectors.

The single-use bioprocessing connectors market has seen significant collaboration and partnerships, driven by the need for scalability, regulatory compliance, and supply chain resilience. These collaborations involve biopharma companies, contract manufacturers, raw material suppliers, and technology providers to advance innovation and address market demands. For instance, in September 2023, Repligen Corporation acquired Metenova, a Sweden-based provider of single-use mixing solutions, to strengthen its fluid management portfolio and enhance capabilities in integrated bioprocessing systems. This move highlights the growing trend of strategic acquisitions aimed at expanding single-use technology offerings and improving end-to-end bioprocessing solutions.

To learn more about this report, Download Free Sample Report

Regulations play a critical role in shaping the market, influencing product design, material selection, sterility assurance, and market adoption. Regulatory bodies such as the FDA (U.S.), EMA (Europe), USP, ISO, and WHO set stringent guidelines to ensure the safety, quality, and performance of Single-use Bioprocessing Connectors used in biopharmaceutical manufacturing.

The single-use bioprocessing connectors industry is experiencing significant product expansion, driven by advancements in aseptic processing, modular biomanufacturing, and automation. Companies are expanding their product portfolios to address the growing demand from biopharmaceutical production, including cell and gene therapies, monoclonal antibodies (mAbs), vaccines, and biosimilars. For instance, in August 2024, Freudenberg Medical expanded its biopharma portfolio by introducing custom single-use assemblies, including Y-connector manifolds, tubing assemblies, and bottle cap systems, for critical fluid transfer applications. This development highlights the growing focus on customized, high-performance single-use solutions to support complex, scalable bioprocessing operations.

The single-use bioprocessing connectors market is experiencing strong regional expansion, driven by increasing biopharmaceutical production, investments in advanced therapies, and regulatory support. While North America and Europe dominate the market, Asia-Pacific (APAC) is witnessing the fastest growth, and Latin America, the Middle East, and Africa (MEA) are emerging markets.

Case Study: CPC Biotech Enabling Modular Single-Use Bioprocessing Systems Through Advanced Connector Technologies

Background

The growing adoption of single-use systems (SUS) in biopharmaceutical manufacturing has increased the need for flexible, scalable, and contamination-free production processes. However, highly customized single-use assemblies often create operational inefficiencies, long lead times, and supply chain challenges.

To address these issues, CPC Biotech developed sterile connector technologies that support modular single-use bioprocessing systems.

Challenge

Biopharmaceutical manufacturers faced several challenges with traditional customized single-use assemblies, including:

• Limited process flexibility

• Difficulty scaling operations

• Long procurement lead times

• Supply chain risks

• Complex technology transfer between facilities

These issues increased operational costs and slowed production timelines.

Solution

CPC Biotech introduced standardized sterile connector technologies, including AseptiQuik and MicroCNX connectors, to enable modular “building block” bioprocessing systems.

These connectors allowed rapid and sterile integration of components such as:

• Tubing manifolds

• Bags

• Filters

• Bioreactors

• Fluid transfer systems

The modular approach enabled plug-and-play assembly and simplified scale-up from the laboratory to commercial production.

Outcomes

• Improved manufacturing flexibility and scalability

• Faster equipment changeovers and reduced downtime

• Lower contamination risk through closed aseptic processing

• Simplified procurement and enhanced supply chain resilience

• Reduced operational costs and improved production efficiency

The case highlights how sterile connector technologies are becoming critical components in the growing market, particularly for biologics, vaccines, and cell & gene therapy manufacturing.

Product Insights

The aseptic connectors segment led the market with the largest revenue share of 47.0% in 2025, owing to their critical role in maintaining sterility across biopharmaceutical processes. Aseptic connectors are widely used in fluid transfer, filtration, mixing, and storage applications, enabling secure, contamination-free connections in single-use systems while reducing cross-contamination risks and improving process efficiency. For instance, in September 2024, Colder Products Company launched the MicroCNX ULT Series, which is the advanced aseptic micro-connectors are designed for cell and gene therapy cryopreservation and can withstand ultra-low temperatures while maintaining sterility, highlighting the growing demand for high-performance connectors in specialized bioprocessing applications.

The connector-integrated tubing interfaces segment is expected to grow at the fastest CAGR during the forecast period. This growth is driven by demand for fully assembled, ready-to-use fluid-transfer systems in biologics manufacturing. These systems combine tubing, sterile connectors, manifolds, valves, filters, and fittings into a single closed fluid pathway, reducing contamination risk and improving operational efficiency. They are widely used in upstream processing, downstream purification, media and buffer transfer, sampling, and fill-finish operations, as well as in cell and gene therapy manufacturing.

Application Insights

The upstream bioprocessing segment led the market with the largest revenue share of 43.0% in 2025. Upstream bioprocessing involves the initial stages of biological drug production, including cell culture, fermentation, and media preparation. Single-use connectors play a critical role in ensuring sterile, contamination-free fluid transfer during these processes.

The fill-finish operations segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing demand for sterile fluid transfer, contamination control, and flexible manufacturing in biologics, vaccines, and cell & gene therapy production. The rising adoption of single-use technologies in aseptic filling processes, along with growing biopharmaceutical manufacturing capacity and stricter regulatory requirements for product safety, is further accelerating demand for reliable single-use connector solutions in fill-finish operations.

End Use Insights

The biopharmaceutical & pharmaceutical companies segment led the market with the largest revenue share of 43.7% in 2025. The growing demand for cell and gene therapies and personalized medicine is driving the adoption of single-use bioprocessing connectors across upstream and downstream processing by these end-users. This is supported by increasing investments in flexible biomanufacturing infrastructure, as companies expand production capacity using single-use technologies to improve efficiency and reduce contamination risks. For instance, in October 2023, Thermo Fisher Scientific expanded its biologics manufacturing facility in St. Louis by adding 58,000 square feet of production space to support complex therapies, including cancer and rare diseases. The expansion includes the integration of single-use bioreactors to enhance scalability and manufacturing flexibility. This development highlights increasing investments in single-use technology-enabled infrastructure to support advanced biologics production.

To learn more about this report, Download Free Sample Report

The CMOs / CDMOs segment is anticipated to register at the fastest CAGR over the forecast period. The rising trend of outsourcing services to Contract Manufacturing Organization and CDMOs has greatly contributed to the expansion of this end-user segment within the global market. As biologics and cell and gene therapies continue to evolve and gain importance in the healthcare sector, biopharmaceutical companies are increasingly seeking cutting-edge technologies to improve the efficiency of their production processes.

Regional Insights

North America dominated the single-use bioprocessing connectors market with the largest revenue share of 47.2% in 2025. This significant market share can be attributed to the expansion of the biotechnology and pharmaceutical sectors, advancements in product offerings, and the rising prevalence of diseases like cancer. In addition, increased investment in drug discovery research is crucial. For instance, in June 2025, Cytiva announced a USD 1.6 billion global investment plan to expand biomanufacturing capacity, including the development of new manufacturing facilities and the expansion of filtration and single-use product lines across North America. This initiative aims to strengthen supply chain resilience and support the growing demand for biologics and single-use technologies.

To learn more about this report, Download Free Sample Report

U.S. Single-use Bioprocessing Connectors Market Trends

The single-use bioprocessing connectors industry in the U.S. accounted for the largest market revenue share in North America in 2025, mainly due to its large-scale biopharmaceutical manufacturing facilities. The biopharmaceutical sector is the most R&D-intensive in the U.S., and its development is a high-impact factor in the industry. Increasing investments in advanced biologics, cell and gene therapies, and widespread adoption of single-use technologies to enhance manufacturing flexibility and reduce contamination risks further support market growth.

Europe Single-use Bioprocessing Connectors Market Trends

The single-use bioprocessing connectors industry in Europe is driven by established biopharmaceutical companies and advanced manufacturing infrastructure. Countries like the UK, France, Italy, Germany, Switzerland, Spain, and the Netherlands hold significant positions in the biopharmaceutical sector. The region hosts several events and summits on innovations in bioprocessing. Strong regulatory frameworks and growing investments in biologics and advanced therapy manufacturing support the adoption of single-use technologies across Europe.

The UK single-use bioprocessing connectors market is growing rapidly, driven by strong government support to strengthen domestic biomanufacturing capabilities and enhance competitiveness against global players. Initiatives such as funding for life sciences innovation, expansion of advanced therapy manufacturing centers, and support for cell and gene therapy development are accelerating the adoption of single-use technologies. In addition, the presence of leading research institutions and increasing collaboration between academia and industry are further contributing to market growth.

The single-use bioprocessing connectors market in Germany is experiencing significant growth. The presence of key players for single-use technology in Germany and contract service providers continuing to invest in the expansion of their single-use capacity are among the factors driving the country’s market.

Asia Pacific Single-use Bioprocessing Connectors Market Trends

The single-use bioprocessing connectors industry in the Asia Pacific is anticipated to grow at the fastest CAGR of 15.1% during the forecast period. The growth of this region is expected to be mainly driven by China and India. Key factors driving the industry growth include an increase in access to technologies, a large patient pool, and an improvement in healthcare infrastructure. The increasing adoption of single-use assemblies by mature players in emerging markets to refine processes is also a significant factor driving the region’s growth. Moreover, the growing biotechnology sector, the presence of many research & academic institutes, and significant investments by market participants are projected to drive the region’s market.

The China single-use bioprocessing connectors market is rapidly expanding due to the increasing demand for biopharmaceuticals, including biologics and biosimilars. The country’s strong focus on developing domestic biomanufacturing capabilities, supported by government initiatives, is further accelerating market growth. In addition, several international companies are expanding their presence through strategic partnerships and joint ventures with local firms to strengthen supply chains and market access. Rising investments in advanced manufacturing technologies and the growing number of biopharma facilities are also contributing to the increased adoption of single-use systems, including connectors, across China.

Latin America Single-use Bioprocessing Connectors Market Trends

The single-use bioprocessing connectors industry in Latin America is experiencing steady growth due to the expansion of the biopharmaceutical and biotechnology sectors across countries such as Brazil and Argentina. The increasing demand for biologics and biosimilars, along with rising healthcare investments, is driving market growth. The adoption of single-use technologies is growing as manufacturers seek cost-effective and flexible production solutions. However, limited local manufacturing capabilities and dependence on imports may slightly restrain market growth in the region.

Middle East & Africa Single-use Bioprocessing Connectors Market Trends

The single-use bioprocessing connectors industry in the Middle East & Africa (MEA) is expected to grow at a moderate CAGR over the forecast period, driven by differences in economic development across countries. Growth is driven by expanding pharmaceutical and biotechnology sectors, and a limited skilled workforce and lower R&D investments remain key challenges. South Africa holds a significant position in the region due to its relatively developed healthcare and life sciences industry. In contrast, the UAE market is witnessing stronger growth, driven by ongoing improvements in healthcare infrastructure and increasing investments in the biopharmaceutical sector.

Key Single-use Bioprocessing Connectors Company Insights

The market players operating in the single-use bioprocessing connectors industry are adopting product approval to increase the reach of their products in the market, improve their availability in diverse geographical areas, and expand to enhance production/research activities. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies. 

Key Single-use Bioprocessing Connectors Companies

The following key companies have been profiled for this study on the single-use bioprocessing connectors market.

• Sartorius AG

• Merck KGaA

• Danaher Corporation

• Saint-Gobain Life Sciences

• Colder Products Company

• Thermo Fisher Scientific Inc.

• Avantor Inc.

• Foxx Life Sciences

• Repligen Corporation

• Entegris Inc.

• Nordson Corporation

• Eldon James

• Watson-Marlow Fluid Technology Solutions

• Savillex

Recent Development

• In January 2025, CPC (Colder Products Company), a subsidiary of Dover Corporation, launched its MicroCNX Nano Series aseptic connectors. These connectors are designed to enhance the efficiency of closed sterile processing in cell and gene therapy. This innovation addresses the industry's reliance on outdated techniques, such as tube welding and biosafety cabinets, which can be cumbersome and time-consuming.

"Now, CGT processing assemblies that include the MicroCNX Nano connectors will allow users to easily click together the connector halves to create a sterile flow path. This is a major advancement for CGT applications."

-Troy Ostreng, Senior Product Manager for CPC's biopharmaceutical business

• In October 2024, Thermo Fisher Scientific Inc. announced the establishment of a Bioprocess Design Center in Genome Valley, Hyderabad, in collaboration with the Government of Telangana. This facility will cover 10,000 square feet and is expected to commence operations in early 2025. Such developments are expected to grow demand for the Single-use Bioprocessing Connectors for bioprocessing applications.

Global Single-use Bioprocessing Connectors Market Report Segmentation

This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global single-use bioprocessing connectors market report based on product, application, end use, and region:

To learn more about this report, Download Free Sample Report

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Aseptic Connectors

    • Tube-to-tube connectors

    • Tube-to-bag connectors

    • Genderless sterile connectors

    • High-flow aseptic connectors

  • Conventional Connectors

    • Luer-based systems

    • Hose barb connectors

    • Quick disconnects

  • Connector-Integrated Tubing Interfaces

    • Pre-attached tubing connector systems

    • Tubing-compatible sterile interfaces

    • Integrated fluid transfer connection sets

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Upstream Bioprocessing

  • Downstream Bioprocessing

  • Fill-finish Operations

  • Fluid Transfer & Sampling Applications

• End Use Outlook (Revenue, USD Billion, 2021 - 2033)

  • Biopharmaceutical & Pharmaceutical Companies

  • CMOs / CDMOs

  • OEM & Assembly Integrators

  • Academic & Research Institutes

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • India

    • Japan

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Delivered Customizations

This report has been delivered with the following In-depth customizations